PubMed:32471903 / 1465-1686 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T22 23-32 CHEBI:35222 denotes inhibitor
T23 23-32 CHEBI:35222 denotes inhibitor
T24 39-42 PR:000000134 denotes TNF
T25 160-172 CHEBI:35718 denotes antimalarial
T26 160-172 CHEBI:35718 denotes antimalarial

Inflammaging

Id Subject Object Predicate Lexical cue
T15 0-221 Sentence denotes Tumour necrosis factor inhibitor (anti-TNF) use was associated with a reduced odds of hospitalisation (OR 0.40, 95% CI 0.19 to 0.81), while no association with antimalarial use (OR 0.94, 95% CI 0.57 to 1.57) was observed.
T15 0-221 Sentence denotes Tumour necrosis factor inhibitor (anti-TNF) use was associated with a reduced odds of hospitalisation (OR 0.40, 95% CI 0.19 to 0.81), while no association with antimalarial use (OR 0.94, 95% CI 0.57 to 1.57) was observed.

hydroxychloroquine

Id Subject Object Predicate Lexical cue hp_id
T1 0-6 Phenotype denotes Tumour http://purl.obolibrary.org/obo/HP_0002664